The eye care providers authored an opinion article that has been published in "The Ocular Surface."
Kaleb Abbott, OD, MS, FAAO, FOWNS, and Andrew Pucker, OD, PhD, FAAO Dipl, FSLS, FBCLA, are advocating for a refreshing of terminology when it comes to artificial drops. In an opinion article published in The Ocular Surface titled “It's time to retire the terms artificial tears and rewetting drops: A call for accurate terminology and updated clinical usage in eye care,” the ODs stated that the term “artificial tears”:
“In contrast to the natural tear film, over-the-counter eye drops commonly referred to as ‘artificial tears’ or ‘rewetting drops’ lack the molecular complexity, biological functionality, and structural sophistication of their namesake. These drops are, in fact, lubricating solutions that provide transient relief from ocular surface symptoms, but they do not replicate the tear film's multifaceted functions,” the authors wrote.
Abbott and Pucker sat down with Optometry Times to detail their suggestions on how other eye care providers can refer to artificial drops with their patients in order to provide the most accurate information and quality care.
Andrew Pucker, OD, PhD, FAAO Dipl, FSLS, FBCLA:
Calling these products “tears” suggests they can replace or replicate the natural tears, which is an extraordinarily complex structure containing thousands of proteins, lipids, mucins, vitamins, and growth factors. No OTC drop comes close to matching this level of biological complexity. Using outdated terminology can mislead patients about what these products can realistically do and may delay more effective treatments when needed. It can also confuse contact lens wearers—many assume these drops are unsafe with lenses, when in reality preservative-free lubricating drops or preserved lubricating drops that are used 4 or fewer times per day have been shown through numerous studies to be safe and effective for treating contact lens discomfort.
Kaleb Abbott, OD, MS, FAAO, FOWNS:
Our recommendation is to retire the terms “artificial tears” and “rewetting drops” and use the more accurate term “lubricating drops.” These products are helpful for symptom relief, but the current terminology creates unrealistic expectations for patients and may inadvertently misguide providers as well. We also encourage journals, manufacturers, and clinicians to adopt consistent, clear terminology that aligns with current science.
Abbott:
Clinicians can improve patient communication by using clearer terminology such as "lubricating drops", which sets accurate expectations and helps patients understand that these products provide short-term symptom relief, not true tear replacement. This clarity also encourages dialogue about additional, more effective treatments when appropriate. Ultimately, more precise language supports better education, better decision-making, and stronger trust in care.
Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.
.png "Optometry Times"){kind=logo}
